Seres Therapeutics
MCRB
#10246
Rank
S$4.26 M
Marketcap
$0.49
Share price
1.11%
Change (1 day)
-60.50%
Change (1 year)

EPS for Seres Therapeutics (MCRB)

EPS in 2023 (TTM): -$1.50

According to Seres Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.47. In 2022 the company made an earnings per share (EPS) of -$3.06 a decrease over its 2021 EPS that were of -$0.95.

EPS history for Seres Therapeutics from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.50-51.06%
2022-$3.06220.55%
2021-$0.95-34.23%
2020-$1.45-15.27%
2019-$1.71-46.09%
2018-$3.189.95%
2017-$2.89-3.49%
2016-$3.00-10.19%
2015-$3.34321.85%
2014-$0.79

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$2.80 91.07%๐Ÿ‡บ๐Ÿ‡ธ USA
-$5.17 252.68%๐Ÿ‡บ๐Ÿ‡ธ USA